论文部分内容阅读
肝癌是一种恶性程度很高的肿瘤,大多数病例发现时已无外科手术指征,不能手术切除的中晚期肝癌患者的平均生存期仅3~6个月。肝动脉灌注化疗栓塞(TACE)是公认的肝癌非手术疗法的首选方法,但由于肝癌特殊的生物学特性及目前对其认识的局限性,包括单纯介入治疗在内的任何一种单一治
Liver cancer is a highly malignant tumor. Most of the cases were found to be without surgical indications. The average survival of patients with unresectable advanced liver cancer was only 3 to 6 months. Transcatheter arterial chemoembolization (TACE) is recognized as the first choice for non-surgical treatment of liver cancer. However, due to the special biological characteristics of liver cancer and the current limitations of its understanding, including simple interventional therapy, including any single treatment